Sagimet Biosciences Inc.
SGMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $223 | $245 | $105 | $145 |
| - Cash | $32 | $42 | $65 | $76 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $190 | $203 | $40 | $69 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$13 | -$12 | -$20 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$13 | -$10 | -$18 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.4 | -0.32 | -0.56 | -0.5 |
| % Growth | -25% | 42.9% | -12% | – |
| Operating Cash Flow | -$10 | -$9 | -$15 | -$11 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$10 | -$9 | -$15 | -$11 |